Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 17/3/20031 min de lectura
Determination of Regulatory Review Period for Purposes of Patent Extension; VITREON; Amendment
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is amending its determination regarding the regulatory review period for purposes of patent extension for VITREON that appeared in the Federal Register of December 17, 1998 (63 FR 69633). FDA is amending the document because the agency agrees with the information provided in a request from the applicant for revision of the regulatory review period.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →